Drs Ursula A. Matulonis and Katherine Fuh discuss the molecular classification and genetics of endometrial cancer as well as when to rebiopsy, research updates, and what's to come in the future.

Ovarian cancer, known for its subtle symptoms, claims thousands of lives annually. Risk factors include age, genetic ...

Optimizing telehealth during public health emergencies to minimize in-person appointments puts less burden on patients and ...

AROUND 7,500 women are diagnosed with ovarian cancer each year in the UK and 4,100 pass away from it. But symptoms of the ...

A missed period is not a direct symptom of ovarian cancer, but can be a coincidental symptom, said Dr. Sampada Dessai.

For patients with relapsed BRCA-mutated ovarian carcinoma, rucaparib produced a median OS of 19.4 months vs 25.4 months with ...

With the potential for future pandemics, Chun Chao, PhD, MS, emphasizes the importance of learning from the COVID-19 pandemic ...

The National Institute of Health and Care Excellence (NICE) has recommended pharmaand’s (pharma&) Rubraca (rucaparib) as a first-line maintenance treatment option for a subset of advanced ovarian ...

In addition, the activation of c-Kit activates the tyrosine kinase signal transduction pathway, which is closely related to the occurrence and development of gynecological tumors, especially ovarian ...

Epithelial ovarian cancer is the most common type of ovarian cancer. About 90 out of 100 tumours of the ovary (90%) are epithelial. Epithelial ovarian cancer starts in the surface layer covering the ...

About Epithelial Ovarian Cancer Epithelial ovarian cancer is the sixth deadliest malignancy among women in the U.S. There are approximately 20,000 new cases of ovarian cancer every year and ...